| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Member Of 10% Owner Group
1 company
Geller Avi is a Member Of 10% Owner Group at Pasithea Therapeutics Corp.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $43K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2022 | KTTA Pasithea Therapeutics Corp. | Member Of 10% Owner Group | Buy | 54,644 | $1.30 | $70,938.84 | New | -21.3% | -55.4% |